poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  1. Zacks Investment ResearchZacks.Com

    Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus

    Zacks highlights strong stock performance from its various rating systems and portfolios. Oportun Financial gained 31% after a Zacks Rank upgrade, Uranium Royalty advanced 67.6% following an Outperform recommendation, and Amgen returned 25.1% over 12 weeks. The article discusses economic conditions marked by geopolitical tensions, rising energy costs, and resilient but cooling labor markets, while showcasing the historical outperformance of Zacks' investment methodologies.

  2. Zacks Investment ResearchNa

    Lilly Builds Neuroscience into a New Long-Term Growth Driver

    Eli Lilly's neuroscience business, currently representing only 2% of revenues, is experiencing strong 32% growth with key products Kisunla and Emgality. The company is aggressively expanding its neuroscience pipeline through acquisitions including AtaiBeckley for treatment-resistant depression therapies, positioning neuroscience as a potential long-term growth driver to diversify beyond its dominant cardiometabolic business.

  3. Zacks Investment ResearchNa

    3 Crypto-Exposed Stocks Riding the Institutional Crypto Wave

    Wall Street's cryptocurrency environment has improved with growing institutional participation through regulated ETFs, regulatory progress via the CLARITY Act, and stablecoin adoption. Bitcoin ETFs saw strong inflows in August-September 2026, while three crypto-related stocks—Figure Technology, Chime Financial, and Paymentus—are highlighted as investment opportunities. However, cryptocurrencies remain vulnerable to interest rate changes and Federal Reserve policy shifts.

  4. Zacks Investment ResearchNa

    ABM Industries (ABM) Q3 Earnings and Revenues Beat Estimates

    ABM Industries reported Q3 2026 earnings of $1.04 per share, beating consensus estimates of $1.01, with revenues of $2.32 billion exceeding expectations by 0.71%. However, the stock has underperformed the S&P 500 year-to-date, gaining 11.2% versus the market's 12.8%. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Business - Services industry ranks in the bottom 24% of Zacks industries.

  5. Zacks Investment ResearchNa

    CAPL or GLP: Which Energy MLP Has the Stronger Investment Case?

    CrossAmerica Partners (CAPL) and Global Partners (GLP) are compared as energy MLPs offering income and fuel market exposure. CAPL offers a 9% yield with improving cash flow and coverage, while GLP provides broader operations, lower leverage, and cheaper valuation. CAPL receives a Zacks Rank #1 (Strong Buy) rating as the better buy despite both showing strong EBITDA and distributable cash flow growth.

  6. Zacks Investment ResearchNa

    New Strong Sell Stocks for September 8th

    Zacks has added three stocks to its Strong Sell list today: Criteo, a performance display advertising company with a 12.9% downward earnings revision; Dine Brands Global, which operates Applebee's and IHOP with a 7.8% downward earnings revision; and Light & Wonder, a games and entertainment company with a 7% downward earnings revision over the last 60 days.

  7. Zacks Investment ResearchNa

    September Asset Allocation Guidelines

    This article is primarily promotional content for Zacks' investment tools and services, featuring their Thematic Investment Screens covering 37 investment themes and their Zacks Rank stock-rating system. The content highlights historical performance claims and directs users to ZacksTrade services.

  8. Zacks Investment ResearchNa

    Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell?

    Merck's stock is trading near its 52-week high, driven by positive phase III data for its Keytruda-Moderna cancer therapy combo and strong fundamentals. Keytruda is expected to reach $35 billion in peak sales by 2028, with the company launching 20 new drugs by 2030. However, Merck faces significant headwinds including Keytruda's 2028 patent expiration, declining Gardasil vaccine sales, and generic erosion of diabetes and other drugs.

  9. The Motley FoolJake Lerch

    Insider Waves Goodbye to 800 Shares of Iconic Specialty Retailer

    Kenneth B. Robinson, Director at Abercrombie & Fitch, sold 800 shares valued at $119,752 on August 28, 2026. Despite the sale, Robinson retains 7,169 shares worth $1.06 million. The transaction follows ANF's impressive 54% one-year return, though the article notes that insider sales can occur for various reasons including tax withholding and prearranged plans.

  10. The Motley FoolBrett Schafer

    If a Stock Market Crash Is Coming, History Says You'll Survive If You Make This Move (Hint: It Does Not Mean Going to Cash)

    Rather than moving to cash during market uncertainty, investors should consider allocating to long-term bonds as a defensive strategy. Bonds tend to appreciate during market downturns when central banks lower interest rates, provide higher yields than cash, and offer portfolio diversification. The article emphasizes that while market crashes are inevitable historically, attempting to time them is futile—instead, building a balanced portfolio with uncorrelated assets like bonds can help investors weather volatility.

  11. Zacks Investment ResearchNa

    International: Update on Global Regions

    This article is primarily promotional content for Zacks' investment tools and services, featuring their Thematic Investment Screens covering 37 investment themes and their Zacks Rank stock-rating system. The content highlights historical performance claims and directs users to ZacksTrade services.

  12. Globenewswire IncNokia Communications

    Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

    Nokia distributed 687,145 treasury shares to participants in its stock-based incentive programs on September 8, 2026, in accordance with program terms. The distribution was based on a board decision from October 2, 2025. Following the distribution, Nokia holds 83,304,077 treasury shares.

  13. The Motley FoolJohn Ballard

    Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million

    Quest Diagnostics CEO J. E. Davis sold 10,000 shares worth $2.4 million on September 1, 2026, under a pre-planned Rule 10b5-1 trading arrangement. The sale represents 8% of his direct holdings, leaving him with $28.9 million in company stock. Analysts view this as a routine portfolio adjustment rather than a sign of concern about the company's fundamentals.

  14. Zacks Investment ResearchNa

    September Equity Style Box Returns

    This article is primarily promotional content for Zacks' investment tools and services, featuring their Thematic Investment Screens covering 37 investment themes and their Zacks Rank stock-rating system. The content highlights historical performance claims and directs users to ZacksTrade services.

  15. Globenewswire IncNokia Communications

    Changes in Nokia Corporation's own shares

    Nokia Corporation transferred 687,145 of its own shares to participants of equity-based incentive plans on September 8, 2026, in accordance with Board resolution from October 2025. Following the transfer, Nokia holds 83,304,077 own shares. The transfer settles the company's commitments under its incentive compensation programs.

  16. Zacks Investment ResearchNa

    ZRS Chart of the Month

    This article is primarily promotional content for Zacks' investment tools and services, featuring their Thematic Investment Screens covering 37 investment themes and their Zacks Rank stock-rating system. The content highlights historical performance claims and directs users to ZacksTrade services.

  17. Zacks Investment ResearchNa

    Tapestry's International Growth Accelerates on China & Europe Gains

    Tapestry, Inc. (TPR) demonstrated robust international expansion in Q4 fiscal 2026, with Europe and Asia-Pacific revenues growing 19% and Greater China surging 28%. Coach brand led gains with 30% growth in Greater China and 25% in Europe. The company forecasts mid-teens growth in Europe and Greater China for fiscal 2027, targeting revenues of $8.4-$8.5 billion. TPR shares have outperformed its industry by 26.3% over the past year and currently hold a Zacks Rank #3 (Hold).

  18. Zacks Investment ResearchNa

    AI Data Explosion: Can WDC Become a Bigger Storage Winner?

    Western Digital is capitalizing on persistent data storage demand driven by AI inference and Agentic AI workloads. The company is ramping 40TB ePMR drives and developing 44TB HAMR technology for 2027, while UltraSMR is expected to reach 60% of nearline exabyte shipments by fiscal 2027. As AI shifts from training to inference and autonomous systems generate massive data volumes, HDDs remain cost-efficient for long-term storage, positioning WDC for sustained capacity-driven growth.

  19. The Motley FoolAnthony Di Pizio

    1 Glorious Growth Stock Down 78% to Buy on the Dip in September

    Docusign stock has fallen 78% from its 2021 peak due to slowing demand post-pandemic, but the company's new AI-powered Intelligent Agreement Management (IAM) platform could reignite growth. With IAM adoption ramping up rapidly and trading at a steep discount to historical valuations, the stock may present a buying opportunity for long-term investors.

  20. The Motley FoolThomas Niel

    UnitedHealth Group Stock Is Up 39.4% in the Last 6 Months. How High Can It Go?

    UnitedHealth Group (UNH) surged 39.4% over six months, driven by strong Q1 earnings and investor confidence in the company's turnaround efforts, including a $3 billion AI investment. However, the stock has pulled back since July due to concerns about rising healthcare costs from GLP-1 drugs and independent dispute resolutions. Trading at 18x estimated 2027 earnings, analysts remain bullish, viewing recent volatility as a potential buying opportunity if management's AI-driven strategy delivers expected mid-to-high teens earnings growth.

  21. SEC EDGARSEC EDGAR

    8-K filing — Federal Home Loan Bank of Indianapolis

    Filed: 2026-09-08 AccNo: 0001331754-26-000177 Size: 198 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh